| Evotec AG. (7/24/17). "Press Release: Evotec and Bayer Advance Endometriosis Programme into Phase 1 Clinical Development and Extend Alliance". Hamburg. |
2017-07-24 |
| Definiens AG. (7/24/17). "Press Release: Definiens Forearms Organization for Strategic Expansion". Munich. |
2017-07-24 |
| Royal Philips. (7/24/17). "Press Release: Philips' Second Quarter Results 2017". |
2017-07-24 |
| Valneva S.E.. (7/24/17). "Press Release: Valneva Receives FDA Fast Track Designation for Its Lyme Disease Vaccine Candidate VLA15". Lyon. |
2017-07-24 |
| Bayer AG. (7/21/17). "Press Release: Phase II Trial of Investigational Anetumab Ravtansine Does Not Meet Primary Endpoint in Second-Line Mesothelioma [Not intended for U.S. and UK Media]". Berlin. |
2017-07-21 |
| Bayer AG. (7/21/17). "Press Release: Bayer’s Xarelto in Combination with Single Antiplatelet Therapy Receives Positive CHMP Opinion for Treatment of Patients with Atrial Fibrillation [...] [Not intended for U.S. and UK Media]". Berlin. |
2017-07-21 |
| Vifor Pharma AG. (7/21/17). "Press Release: European Commission Approves Marketing Authorisation for Veltassa". |
2017-07-21 |
| Oryzon Genomics S.A.. (7/20/17). "Press Release: Oryzon to Regain Rights to ORY-1001 (RG6016)". Barcelona & Cambridge, MA. |
2017-07-20 |
| Spindiag GmbH. (7/20/17). "Press Release: SpinDiag Raises 1.6 Mio EUR Seed-Capital to Bring Its Revolutionary Point-of-Care Screening System for Antibiotic Resistance to Initial Testing in Hospitals". Freiburg. |
2017-07-20 |
| CureVac AG. (7/20/17). "Press Release: CureVac to Receive Patent Claiming the Combination of mRNA Vaccines with Anti-PD-1 Antibodies". Tübingen. |
2017-07-20 |
| Philogen S.p.A.. (7/20/17). "Press Release: Philogen Enters into Multi-target Research Agreement with Boehringer Ingelheim in the Field of DNA-encoded Chemistry". Siena. |
2017-07-20 |
| Philips. (7/20/17). "Press Release: Chief Business Leader of Philips’ Personal Health Businesses Pieter Nota to Leave Company". Amsterdam. |
2017-07-20 |
| Ionicon Analytik GmbH. (7/20/17). "Press Release: Ionicon Launches AMC-Monitor T-1000 for the Semiconductor Industry". Innsbruck. |
2017-07-20 |
| Basilea Pharmaceutica Ltd.. (7/20/17). "Press Release: Basilea Announces Completion of the License Agreement with Pfizer for Antifungal Cresemba for Europe, Russia, Turkey and Israel". Basel. |
2017-07-20 |
| Sartorius AG. (7/19/17). "Press Release: Sartorius Supervisory Board Elects Dr. Lothar Kappich as Its Chairman". Göttingen. |
2017-07-19 |
| Novimmune S.A.. (7/18/17). "Press Release: Novimmune and Shire Sign License Agreement Deepening Bispecific Antibody Research Collaboration". Geneva. |
2017-07-18 |
| Agilent Technologies Inc.. (7/18/17). "Press Release: Hans E. Bishop to Join Agilent’s Board of Directors. CEO of Juno Therapeutics Brings Deep Knowledge of the Biopharma Industry". Santa Clara, CA. |
2017-07-18 |
| Royal Philips. (7/18/17). "Press Release: Philips to Strengthen Its Ultrasound Business with the Acquisition of Clinical Applications and Imaging Software Company TomTec". Amsterdam. |
2017-07-18 |
| Humabs BioMed S.A.. (7/18/17). "Press Release: Humabs BioMed and University of California, Berkeley Announce Publication of Data for Novel Antibody-based Assay to Detect Zika Virus Infection". Bellinzona & Berkeley, CA. |
2017-07-18 |
| 4SC AG. (7/18/17). "Press Release: 4SC Licenses Kv1.3 Inhibitors to Maruho. Maruho to Receive Exclusive Worldwide License on 4SC’s Preclinical Inhibitors of the Kv1.3 Ion Channel". Planegg-Martinsried. |
2017-07-18 |
| Novartis AG. (7/18/17). "Press Release: Q2 Results Confirm Full Year Guidance". Basel. |
2017-07-18 |
| Eurofins Scientific. (7/18/17). "Press Release: Eurofins Issues EUR 650m New Euro Bond". |
2017-07-18 |
| Autolus Therapeutics Ltd.. (7/18/17). "Press Release: Autolus Announces Senior Leadership Appointments". London. |
2017-07-18 |
| BASF SE. (7/17/17). "Press Release: BASF and Kaiima Announce Collaboration to Identify Novel Herbicide Resistance Traits Using the EP Technology Platform". Limburgerhof & Moshav Sharona. |
2017-07-17 |
| Eurofins Scientific. (7/17/17). "Press Release: Eurofins Announces the Potential Launch of a New Senior EUR 500m Bond on the Back of Strong M&A Activity". |
2017-07-17 |
| VeroVaccines GmbH. (7/17/17). "Press Release: VeroVaccines GmbH Founded in Halle (Saale), Germany". |
2017-07-17 |
| Novartis AG. (7/14/17). "Press Release: Novartis Confirms 5 Year Data for First and Only Fully-human IL-17A Inhibitor Cosentyx Reinforcing Sustained Efficacy and Safety Profile in Psoriasis". Basel. |
2017-07-14 |
| PreOmics GmbH. (7/14/17). "Press Release: Diagenode and PreOmics Launch New Streamlined Sample Preparation Solution for Proteomic Analyses". Liège, Denville & Martinsried. |
2017-07-14 |
| Novartis AG. (7/13/17). "Press Release: Novartis CAR-T Cell Therapy CTL019 Unanimously (10-0) Recommended for Approval by FDA Advisory Committee to Treat Pediatric, Young Adult r/r B-cell ALL". Basel. |
2017-07-13 |
| MorphoSys AG. (7/13/17). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Received US FDA Approval for Tremfya (Guselkumab) for the Treatment of Moderate to Severe Plaque Psoriasis". Planegg-Martinsried. |
2017-07-13 |
| BASF SE. (7/13/17). "Press Release: BASF Introduces First New Class of Public Health Insecticide for Malaria Prevention in more than 30 Years". Limburgerhof. |
2017-07-13 |
| Wilex AG. (7/13/17). "Press Release: Wilex Reports on First Half-year". Munich. |
2017-07-13 |
| Johnson & Johnson Inc.. (7/13/17). "Press Release: Janssen Announces U.S. FDA Approval of Tremfya (guselkumab) for the Treatment of Moderate to Severe Plaque Psoriasis". Horsham, PA. |
2017-07-13 |
| Epigenomics AG. (7/12/17). "Press Release: Epigenomics AG – Voluntary Public Takeover Offer by Summit Hero Holding Not Successful". Berlin. |
2017-07-12 |
| Merck KGaA. (7/12/17). "Press Relase: Merck Refines Western European Life Science Production Site Network". Darmstadt. |
2017-07-12 |
| Creathor Venture Management GmbH. (7/11/17). "Press Release: Creathor Venture Invests in AI-enabled Clinical Genetic Testing Company Blueprint Genetics as Part of an up to EUR 14 Million Financing Round". Bad Homburg v. d. H.. |
2017-07-11 |
| Numares AG. (7/11/17). "Press Release: Numares AG Achieves Key Milestone – Identifies Candidate Metabolomic Network for Bladder Cancer Diagnostics". Regensburg. |
2017-07-11 |
| Genedata AG. (7/11/17). "Press Release: Genedata Selector Expands Partnership with AB Enzymes". Basel. |
2017-07-11 |
| Enterome S.A.. (7/11/17). "Press Release: Enterome and Nestlé Health Sciences Launch New Diagnostics Company". Paris. |
2017-07-11 |
| Noxxon Pharma N.V.. (7/11/17). "Press Release: Noxxon Pharma Announces Prospectus Publication and Share Transfer to the Public Offering Compartment of the EuroNext Growth Market". Berlin. |
2017-07-11 |
| Silence Therapeutics plc. (7/10/17). "Press Release: IP Update". |
2017-07-10 |
| CRISPR Therapeutics AG. (7/10/17). "Press Release: CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration". Cambridge, MA & Basel. |
2017-07-10 |
| Phenex Pharmaceuticals AG. (7/10/17). "Press Release: Phenex AG Announces Milestone Payment from Janssen for the Entry of RORgt Inhibitor into Phase I". Ludwigshafen. |
2017-07-10 |
| Stada Arzneimittel AG. (7/10/17). "Press Release: Stada Supports Renewed Improved Takeover Offer Announced by Bain Capital and Cinven". Bad Vilbel. |
2017-07-10 |
| Curetis N.V.. (7/7/17). "Press Release: Curetis to Attend Key Investor and Scientific Conferences in the Third Quarter 2017". Amsterdam & Holzgerlingen. |
2017-07-07 |
| Evotec AG. (7/6/17). "Press Release: Evotec Received Funding from IFB Hamburg to Identify Antibody-mediated T-Cell Immunotherapies". Hamburg. |
2017-07-06 |
| Epigenomics AG. (7/6/17). "Press Release: Epigenomics AG Issues Change in Guidance for Financial Year 2017". |
2017-07-06 |
| 4SC AG. (7/6/17). "Press Release: 4SC AG Secures EUR 41 Million from Successful Capital Increase [Not for US, AU, CA, JP or ZA]". Planegg-Martinsried. |
2017-07-06 |
| Evolva Holding S.A.. (7/6/17). "Press Release: Neil Goldsmith Stepping Down as CEO and Board Member of Evolva". |
2017-07-06 |
| Oxford Biomedica plc. (7/6/17). "Press Release: Oxford BioMedica Announces a Major Supply Agreement". Oxford. |
2017-07-06 |
| Lonza Group Ltd.. (7/6/17). "Press Release: Lonza Completes Acquisition of Capsugel to Create Leading Integrated Solutions Provider to the Global Pharma and Consumer Healthcare Industries". Basel. |
2017-07-06 |
| CRISPR Therapeutics AG. (7/5/17). "Press Release: CRISPR Therapeutics to Present at the Piper Jaffray GenomeRx Symposium". Basel & Cambridge, MA. |
2017-07-05 |
| Horizon Discovery Group plc. (7/5/17). "Press Release: Horizon Discovery Takes Exclusive License for Novel Transposon-Based Gene Editing Technology Platform". Cambridge. |
2017-07-05 |
| Seventure Partners. (7/5/17). "Press Release: Health for Life Capital Participates in $13.2m Financing of Japanese Microbiome Leader Anaeropharma Science". Paris. |
2017-07-05 |
| Roche Diagnostics GmbH. (7/5/17). "Pressemitteilung: Roche weiht Neubauten des Biotechnologie-Zentrums in Penzberg ein. Investitionen am Roche Standort Penzberg von 600 Millionen Euro". Penzberg. |
2017-07-05 |
| Eurofins Scientific. (7/4/17). "Press Release: Eurofins Announces AOAC and AFNOR Certification for BACGene and BACSpec Listeria Kits". |
2017-07-04 |
| Noxxon Pharma N.V.. (7/4/17). "Press Release: Noxxon Announces First Patients Treated in Phase I/II Clinical Trial of NOX-A12 Combined with Keytruda in Metastatic Pancreatic and Colorectal Cancer". Berlin. |
2017-07-04 |
| Zealand Pharma A/S. (7/3/17). "Press Release: Zealand Initiates First Phase 3 Trial with Dasiglucagon for the Treatment of Severe Hypoglycemia in Diabetes". Copenhagen. |
2017-07-03 |
| Silence Therapeutics plc. (7/3/17). "Press Release: Change of Adviser". |
2017-07-03 |
| Silence Therapeutics plc. (7/3/17). "Press Release: Issue of Claim in the UK High Courts". |
2017-07-03 |
| Analytik Jena AG. (6/30/17). "Press Release: Analytik Jena Sells AJ Blomesystem". Jena & Cologne. |
2017-06-30 |
| Oxford Biomedica plc. (6/30/17). "Press Release: Oxford BioMedica Announces Refinancing of Debt Facility". London. |
2017-06-30 |
| mySugr GmbH. (6/30/17). "Press Release: mySugr Joins the Roche family". San Diego, CA. |
2017-06-30 |
| iTeos Therapeutics S.A.. (6/29/17). "Press Release: iTeos Therapeutics Appoints Mohamed Ragab, M.D., as Vice President, Corporate Development". Gosselies. |
2017-06-29 |
| Arbeitskreis der BioRegionen. (6/28/17). "Press Release: Dr. Hinrich Habeck folgt nach sechs Jahren Dr. Klaus Eichenberg in seinem Amt. Der neue Sprecher des AK BioRegio setzt auf Fortführung des Erfolgskurses". Berlin. |
2017-06-28 |
| Evotec AG. (6/28/17). "Press Release: Evotec Expands iPSC Drug Discovery Leadership through Strategic Collaboration with Censo Biotechnologies". Hamburg. |
2017-06-28 |
| Cellnovo. (6/28/17). "Press Release: Cellnovo Signs Expanded Agreement to Build Second Production Line with Flex". Paris. |
2017-06-28 |
| Cellectis S.A.. (6/28/17). "Press Release: Cellectis Appoints Rainer Boehm, M.D. and Hervé Hoppenot to Board of Directors". New York, NY. |
2017-06-28 |
| Indi Molecular. (6/28/17). "Press Release: Indi Molecular Raises $11.5M Series A to Accelerate PCC Platform Development". Culver City, CA. |
2017-06-28 |
| BioGeneration Ventures B.V.. (6/27/17). "Press Release: BioGeneration Ventures Fund III Secures EUR 66m, Exceeding EUR 50m Target". Naarden. |
2017-06-27 |
| Selexis S.A.. (6/27/17). "Press Release: Selexis Announces Commercial License Agreement with Takeda for the Development of Fusion Proteins". Geneva. |
2017-06-27 |
| Miltenyi Biotec GmbH. (6/27/17). "Press Release: Miltenyi Biotec Acquires Sensovation". |
2017-06-27 |
| Oculis ehf.. (6/27/17). "Press Release: Eye-drop for Diabetic Retinopathy – Successful Eurostars grant Application". Reykjavik. |
2017-06-27 |
| Bruker Corporation. (6/26/17). "Press Release: Bruker Announces Novel NMR Phenomics Research Capabilities". Brisbane. |
2017-06-26 |
| CureVac AG. (6/26/17). "Press Release: CureVac Expands GMP Production Capacities for RNA Products". Tübingen. |
2017-06-26 |
| EQT Partners. (6/24/17). "Press Release: EQT VII to Invest in Global »Hidden Champion« and Medical Mobility Technology Market Leader Ottobock". |
2017-06-24 |
| Tecan Group Ltd.. (6/23/17). "Press Release: DiaSorin and Tecan to Collaborate in New Platform Development". Saluggia & Männedorf. |
2017-06-23 |
| Merck KGaA. (6/23/17). "Press Release: Cladribine Tablets Receives Positive CHMP Opinion for Treatment of Relapsing Forms of Multiple Sclerosis". Darmstadt. |
2017-06-23 |
| NMI TT Pharmaservices. (6/22/17). "Press Release: NMI TT Pharmaservices and Charité Awarded Grant for Development of Protein Profiling for Individualization of Tumor Therapy". Berlin. |
2017-06-22 |
| DiaSorin S.p.A.. (6/22/17). "Press Release: DiaSorin and Qiagen Sign Collaboration to Expand Liaison Test Menu througth Adoption of Select Qiagen Assays". Saluggia, Hilden & Germantown, MD. |
2017-06-22 |
| Evotec AG. (6/22/17). "Press Release: »Lab282« Accelerates with Second Round Funding". Hamburg. |
2017-06-22 |
| Thermo Fisher Scientific Inc.. (6/22/17). "Press Release: FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies". Carlsbad, CA. |
2017-06-22 |
| Waters Corporation. (6/22/17). "Press Release: Waters Corporation Elects Flemming Ornskov to Board of Directors". Milford, MA. |
2017-06-22 |
| Repare Therapeutics Inc.. (6/22/17). "Press Release: Repare Therapeutics Raises US$68 Million Series A. Novel Cancer Company Founded by Versant Ventures". |
2017-06-22 |
| Boehringer Ingelheim. (6/21/17). "Press Release: New Data Reveal High Rates of Stroke History in Asymptomatic Atrial Fibrillation Patients". Ingelheim. |
2017-06-21 |
| Invent Farma Holding Spain S.L.. (6/21/17). "Press Release: Invent Farma / Neuraxpharm Group Announces the Acquisition of FB Health in Italy". Barcelona & Düsseldorf. |
2017-06-21 |
| InflaRx GmbH. (6/21/17). "Press Release: InflaRx Promotes Othmar Zenker, M.D. to Newly Created Position of Chief Medical Officer". Jena. |
2017-06-21 |
| Shimadzu Europe GmbH. (6/21/17). "Press Release: Shimadzu Has Acquired AlsaChim, a Specialist for High-quality Analytical Isotope Labeled Standards". |
2017-06-21 |
| OBN (UK) Ltd.. (6/20/17). "Press Release: OBN (UK) and Eurasanté (FR) Announce the Launch of BioSeed. A New European Equity Investment Event to Support Early-Stage Companies in Life Sciences". Oxford. |
2017-06-20 |
| Merck KGaA. (6/20/17). "Press Release: Merck Ventures Creates New Immuno-Oncology Company iOnctura". Darmstadt. |
2017-06-20 |
| Evotec AG. (6/20/17). "Press Release: Evotec Announces Strategic Investment in Facio Therapies to Support Development of Novel FSHD Therapy". Hamburg. |
2017-06-20 |
| Affiris AG. (6/20/17). "Press Release: Vaccine that Lowers Cholesterol in Mice Offers Hope of Immunising against Cardiovascular Disease". |
2017-06-20 |
| Debiopharm International SA. (6/20/17). "Press Release: Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor". Craigavon & Lausanne. |
2017-06-20 |
| PerkinElmer, Inc.. (6/19/17). "Press Release: PerkinElmer to Acquire Euroimmun for Approximately $1.3 Billion". Waltham, MA. |
2017-06-19 |
| CRISPR Therapeutics AG. (6/19/17). "Press Release: CRISPR Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China". Basel. |
2017-06-19 |
| Gamida Cell Ltd.. (6/19/17). "Press Release: Gamida Cell Announces $40 Million Private Financing". Jerusalem. |
2017-06-19 |
| Intellia Therapeutics, Inc.. (6/19/17). "Press Release: Intellia Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China". Cambridge, MA. |
2017-06-19 |
| TxCell S.A.. (6/19/17). "Press Release: TxCell Appoints Lentigen Technology, Inc. to Manufacture the Lentiviral Vector for Its First CAR-Treg Program in Transplant Rejection". Valbonne. |
2017-06-19 |
| Wilex AG. (6/19/17). "Press Release: Wilex Subsidiary Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates". Munich. |
2017-06-19 |
| Novartis AG. (6/19/17). "Press Release: Sandoz Receives Approval in Europe for Rixathon (Biosimilar Rituximab) to Treat Blood Cancers and Immunological Diseases". Holzkirchen. |
2017-06-19 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 48 49 50 ... 53 54 55 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
